BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31200660)

  • 1. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
    Zhao XT; Zhang CF; Liu QJ
    BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Trimetazidine in Limiting Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Wang C; Chen W; Yu M; Yang P
    Angiology; 2021 Jul; 72(6):511-523. PubMed ID: 33472383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
    Pang Z; Zhao W; Yao Z
    Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.
    Shehata M
    J Interv Cardiol; 2014 Oct; 27(5):472-81. PubMed ID: 25174952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicorandil treatment in patients with acute myocardial infarction: a meta-analysis.
    Iwakura K; Ito H; Okamura A; Koyama Y; Date M; Higuchi Y; Inoue K; Kimura R; Nagai H; Imai M; Toyoshima Y; Ozawa M; Ito N; Okazaki Y; Shibuya M; Suenaga H; Kubota A; Fujii K
    Circ J; 2009 May; 73(5):925-31. PubMed ID: 19325192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
    Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
    Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Ji Z; Zhang R; Lu W; Ma G; Qu Y
    Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
    JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
    Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
    [No Abstract]   [Full Text] [Related]  

  • 12. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials.
    Li Y; Liu H; Peng W; Song Z
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):855-865. PubMed ID: 30079778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
    Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
    Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
    Wu M; Huang Z; Xie H; Zhou Z
    PLoS One; 2013; 8(10):e78231. PubMed ID: 24167609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis.
    Zhou J; Xu J; Cheng A; Li P; Chen B; Sun S
    J Int Med Res; 2020 Nov; 48(11):300060520967856. PubMed ID: 33249959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
    Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
    Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).
    Kawakita N; Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Nakamura K; Ito H;
    PLoS One; 2018; 13(4):e0194623. PubMed ID: 29659585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.